Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease

Drug repurposing is the most rapid and economic way nowadays to rapidly provide effective drugs for our pandemic coronavirus disease 2019 (COVID-19). It was a great debate about ARBs whether to be stopped or continued for patients using them especially at the beginning of the COVID-19 pandemic. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alnajjar, Radwan, Mostafa, Ahmed, Kandeil, Ahmed, Al-Karmalawy, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713577/
https://www.ncbi.nlm.nih.gov/pubmed/33294721
http://dx.doi.org/10.1016/j.heliyon.2020.e05641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713577/
https://www.ncbi.nlm.nih.gov/pubmed/33294721
http://dx.doi.org/10.1016/j.heliyon.2020.e05641

Ejemplares similares